Benzinga's M&A Chatter for Tuesday February 4, 2014
February 04, 2014 at 17:30 PM EST
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday February 4, 2014: Myriad Genetics to Acquire Crescendo Bioscience for $275M in Cash The Deal:Myriad Genetics (NASDAQ: MYGN ) announced Tuesday that it has agreed to acquire Crescendo Bioscience for $270 million in cash. The deal